|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 51/00 | |
| A61K 39/42 | |||
| A61K 39/40 | |||
| A61K 47/18 | |||
| A61K 47/42 |
| (11) | Patento numeris | 2656859 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13173674.6 |
| Europos patento paraiškos padavimo data | 2005-03-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-10-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-10-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 550015 P | 2004-03-03 | US |
| (72) |
Dake, Michael D., US
Waugh, Jacob M., US
|
| (73) |
ReVance Therapeutics, Inc.,
7555 Gateway Blvd., Newark, CA 94560,
US
|
| (54) | Topical application and transdermal delivery of botulinum toxins |
| Topical application and transdermal delivery of botulinum toxins |